Acro Biomedical ACBM
OTC ACBM
$0.03 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Acro Biomedical (ACBM) Other Operating Expenses (2015 - 2023)

Acro Biomedical (ACBM) posted Other Operating Expenses of $492000.0 for Q3 2023, up 6592.97% on a QoQ basis from $7351.0 in Q4 2016.

Analysis

Acro Biomedical (ACBM) Other Operating Expenses (2015 - 2023) Analysis & Trends

Acro Biomedical has reported Other Operating Expenses for 3 years, with the latest figure at $492000.0 in Q3 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $492000.0 in Q3 2023; TTM through Jun 2024 was $492000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $492000.0, changed N/A from the prior year.
  • Other Operating Expenses was $492000.0 for Q3 2023 at Acro Biomedical, up from $7351.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $492000.0 in Q3 2023, with the low at $492000.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Colgate Palmolive 70.27 Bn 68.90 Bn 3.30 Bn
2 Kenvue 34.17 Bn 33.06 Bn 2.30 Bn
3 Kimberly Clark 32.86 Bn 31.91 Bn 1.60 Bn
4 Bath & Body Works 3.85 Bn 3.05 Bn 692.00 Mn
5 Prestige Consumer Healthcare 2.32 Bn 2.26 Bn -
6 Perrigo 1.99 Bn 1.59 Bn 313.90 Mn
7 Herbalife 1.32 Bn 946.20 Mn 1.03 Bn
8 Edgewell Personal Care 1.24 Bn 842.99 Mn 242.50 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn -
10 Acro Biomedical 1.80 Mn 1.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 492,000.00
Dec 31, 2016 7,351.00
Sep 30, 2016 5,141.00
Jun 30, 2016 17,107.00
Mar 31, 2016 6,332.00
Dec 31, 2015 13,793.00
Sep 30, 2015 2,325.00